# Embolectomy in Acute SYlvian Thrombosis in Refractory or Ineligible Patients to ALteplase

> **NCT02216565** · NA · TERMINATED · sponsor: **Fondation Ophtalmologique Adolphe de Rothschild** · enrollment: 2 (actual)

## Conditions studied

- Stroke, Acute

## Interventions

- **OTHER:** Hospitalization in specialized neuro-vascular unit
- **DRUG:** Alteplase if patient is eligible
- **OTHER:** Supportive care
- **PROCEDURE:** Endovascular treatment

## Key facts

- **NCT ID:** NCT02216565
- **Lead sponsor:** Fondation Ophtalmologique Adolphe de Rothschild
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-12-01
- **Primary completion:** 2015-08-31
- **Final completion:** 2017-08-24
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** After results of other studies published : EASY study became lapsed
- **Last updated:** 2017-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02216565

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02216565, "Embolectomy in Acute SYlvian Thrombosis in Refractory or Ineligible Patients to ALteplase". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02216565. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*